AMJ Podcast | Episode 1: Harnessing Imaging Biomarkers in Asthma: Lessons from VESTIGE - Part 2/2
Join us for this two-episode mini-series featuring lead study authors, Mario Castro and Njira Lugogo, as they discuss key findings from the VESTIGE trial and their implications on asthma care.
Uncover:
· The importance of patient phenotyping: How can biomarkers and imaging improve asthma manag…
AMJ Podcast | Episode 1: Harnessing Imaging Biomarkers in Asthma: Lessons from VESTIGE - Part 1/2
Join us for this two-episode mini-series featuring lead study authors, Mario Castro and Njira Lugogo, as they discuss key findings from the VESTIGE trial and their implications on asthma care.
Uncover:
· The importance of patient phenotyping: How can biomarkers and imaging improve asthma manag…
Jennifer Keeley, DPN and Mary Whittenhall, MSN - phaware® interview 550
Jennifer Keeley and Mary Whittenhall, experienced nurse practitioners in the field of pulmonary hypertension, discuss the management of cough in patients receiving inhaled therapies for pulmonary hypertension and interstitial lung disease. #GossamerBioPartner #sponsored This Special Edition epi…
S4, E2: From Medicine to IPOs - Dr Sheila Gujrathi on Raising Biotech Against the Odds
In this episode, we focus on the personal journey of Sheila Gujrathi, a physician turned biotech builder whose career spans medicine, big pharma, rapid IPOs, and billion dollar exits. We explore what it takes to raise biotech across cycles, from early clinical development to public markets, and how…
Episode 174 - February 27, 2026
On this week’s episode, Tess Cameron, Josh Schimmer, Brian Skorney, and special guest Adam Feuerstein kick off with regulatory updates, including the FDA’s rejection of Atara Biotherapeutics and Pierre Fabre Pharmaceuticals’ cell therapy, Ebvallo -- a therapy that should have been approvable. The c…
Barclays Miami: Barclays' Senior Biotech Analyst Ellie Merle shares her take on biotech and thoughts on companies she covers that have been in the news
She discusses uniQure, Moderna, BridgeBio, Gossamer Bio and more.
Dr. Sheila Gujrathi: Leading with Reflection in a World That Needs Change
Today we're Marching for Change with Dr. Sheila Gujrathi, a mother, sister, daughter, and a biotech entrepreneur and executive, healthcare investor, drug developer, and speaker with over 25 years of experience in the biotech and pharmaceutical industries. She has founded, built, and run numerous bi…
S4, E6: Investor Spotlight: From Cancer Physician to Biotech Investor, with Dr Jakob Dupont of Sofinnova Investments
In this special Investor Spotlight edition of Raising Biotech, Surani sits down with Dr. Jakob Dupont, Executive Partner at Sofinnova Investments, to explore one of the most unusual career trajectories in biotech. Before becoming a venture investor, Dupont spent decades as a physician, cancer resea…
Modernizing Finance Without Losing the Human Element
In this episode of CFO Weekly, Jill Howe, Chief Financial Officer at Lineage Cell Therapeutics, joins Megan Weis to explore how finance leaders can modernize their teams through technology while keeping people at the center of transformation. Lineage Cell Therapeutics is a biotech company developin…
CME/CE Podcast: Emerging Agents in PAH - Targeting Novel Pathways
For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:
https://www.mycme.com/courses/emerging-agents-in-pulmonary-arterial-hypertension-10829
Program Description
This enduring educational activity provides a comprehensi…
PODCAST-ZOEKMACHINE
U kunt onze website gebruiken om3,828,991podcasts en196,507,194afleveringen te zoeken op mensen, plaatsen of onderwerpen.
I have no special talent. I am only passionately curious, and
I listen to podcasts.
‐ Albert "Llamacorn" Einstein
BEWERKEN
Bedankt voor uw hulp bij het up-to-date te houden van de podcast-database .
